Stephen P. Anthony, DO, molecular hematologist & oncologist
A native of Erie, Pennsylvania, Dr. Stephen Anthony attended the Philadelphia College of Osteopathic Medicine, where he received his Doctor of Osteopathic Medicine degree in 1988. He completed his internal medicine training at Hahnemann University Hospital in Philadelphia, where he earned the Intern Superior Performance Award, the Excellence in Clinical Teaching Award, and the Resident Superior Performance Award. He was also named Resident of the Year in 1991.
Dr. Anthony then served a tour of duty with the U.S. Air Force at Holloman AFB, achieving the rank of major. He was assigned as a flight surgeon to the F117A Stealth Fighter squadron and deployed to Saudi Arabia, Kuwait, and other Persian Gulf countries. While at Holloman, he was named the Director of Emergency Services, where he oversaw the ER and the contracted civilian staff.
Following military service, Dr. Anthony completed his hematology and oncology training at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. At Dartmouth, he began his basic molecular oncology research and participation in new drug development clinical trials. He is board-certified in medical oncology, with a sub-specialty interest in breast cancer, and is an inaugural graduate of the School of Breast Oncology – the only medical oncologist in Spokane with this credential.
Dr. Anthony spent nine years in private practice, eight of which were in Spokane at Cancer Care Northwest, where he successfully developed a Phase I research program and participated in the development of several cancer drugs that are now on the market. Dr. Anthony also played an active teaching role with internal medicine residents in Spokane as a clinical assistant professor of medicine at the University of Washington Medical School.
At the time of his departure, Dr. Anthony was the number two accruing physician in the country for clinical trials for the US Oncology Network.
The next two years were spent at Translational Genomics Research Institute (TGen), a nonprofit biotechnical institute. Dr. Anthony served as senior investigator, director of TGen’s Phase I clinical unit at Scottsdale Healthcare Shea, and chief medical officer for TGen Drug Development Services. Dr. Anthony has two funded clinical research projects on which he continues to collaborate with his colleagues at TGen.
Dr. Anthony is known in the cancer research field and has published and lectured in the area of understanding cancer drug resistance, breast and gynecologic cancer therapy, and the application of new genomic technologies for drug development and treatment of oncology patients in a more targeted fashion.